SCHEMBL5379523

SCHEMBL5379523

Cc1ccc(C(F)(F)F)c(-n2nc(-c3ccc(O)cc3)c(-c3ccccc3)c2-c2ccc(O)cc2)n1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.45
ESR2 Q92731 5/20 0.45
TDP1 Q9NUW8 1/20 0.45
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
USP2 O75604 1/20 0.39
USP7 Q93009 1/20 0.37
PTGER1 P34995 2/20 0.36
POLB P06746 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PTGS1 P23219 1/20 0.35
MAPK1 P28482 2/20 0.35
GSK3B P49841 1/20 0.35
TOP1 P11387 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747185 0.82 ESR1 (0.46) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5217068 0.81 ESR1 (0.47) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5219128 0.78 ESR1 (0.44) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5216396 0.77 ESR1 (0.47) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5217840 0.76 ESR1 (0.43) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5215623 0.74 KMT2A (0.44) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5215071 0.74 ESR1 (0.47) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5218096 0.74 KMT2A (0.41) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5214054 0.73 KMT2A (0.51) ESR1ESR2TDP1KMT2AMEN1
SCHEMBL5214926 0.72 ESR1 (0.55) ESR1ESR2TDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39708-E1 Estrogen receptor modulators CHIRON CORPORATION (US) 2007-06-26 US disclosed
US-6291505-B1 PYRAZOLE ESTROGEN RECEPTOR AGONIST AND ANTAGONIST CHIRON CORPORATION 2001-09-18 US disclosed